Balar, Agustin .
HRN: 09-17-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/07/2024
02/13/2024
IV
2.5 G
Q8
CAP HR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes